💥🇺🇸#VRTX Vertex Pharmaceuticals stock price target raised to $305 from $281 at J.P. Morgan💥🇺🇸#SGEN Seattle Genetics stock price target raised to $179 from $150 at J.P. Morgan💥🇺🇸#LRCX Lam Research stock price target raised to $435 from $270 at B. Riley FBR⚠️🇺🇸#BIIB Biogen stock price target cut to $272 from $293 at J.P. Morgan💥🇺🇸#PYPD POLYPID started at OUTPERFORM with $23 stock price target at Raymond James💥🇺🇸#EXK ENDEAVOUR SILVER started at BUY with $4.75 stock price target at B. Riley FBR⚠️🇺🇸#FNHC FEDNAT downgraded to OUTPERFORM from STRONG BUY at Raymond James⚠️🇺🇸#NDAQ NASDAQ downgraded to MARKET PERFORM from OUTPERFORM at Raymond James
Акции США
LRCX
Курс акций Lam Research - новое целевое значение $435
Lam Research получил новую целевую цену $435 от B. Riley FBR.
Контекст по активу
Lam Research Corporation (LRCX). Бумага относится к сектору "Технологии". Последняя цена: 235,12 USD. Текущая дневная динамика: 0%. Актив есть в портфелях 142 пользователей FinPlan. Капитализация около 33,1 млрд USD.